Add BrightSurf on Google Email

A rare case of Parkinson's disease reveals molecular changes in platelets during disease progression

A rare case of early-onset Parkinson's disease reveals molecular changes in platelets associated with disease progression. The study identified changes in gene expression in platelets, including those involved in mitochondrial function and protein synthesis, providing insights into molecular processes involved in disease progression.

SourceGermans Trias i Pujol Research Institute·JournalMovement Disorders·TypeCase study·DateOct 30, 2026

Controlled inhalation of thin air may alleviate Parkinson’s symptoms

Researchers found that short, controlled exposure to low-oxygen air reduces cortisol and leptin levels, increases adiponectin, and improves inflammation markers in people with Parkinson's disease. However, more in-depth studies are needed to confirm the effects on sleep and reorganize the sleep-wake cycle.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalParkinsonism & Related Disorders·DateOct 28, 2026

IIT Gandhinagar startup Oreejoy wins Boeing BUILD National Finals for AI-powered wearable device

Oreejoy's AI-powered wearable device uses pressure sensing, signal processing, and artificial intelligence to assess mobility and provide personalized sensory cues for people with neurological disorders. The startup aims to make effective diagnostics and rehabilitation more accessible, improving quality of life for patients undergoing ...

New study reveals timing of brain surgery is crucial for preserving memory and thinking in genetically defined Parkinson’s patients

A new study found that the timing of Deep Brain Stimulation (DBS) surgery is critical for preserving cognitive function in Parkinson’s disease patients with a specific genetic mutation. Performing DBS within the first seven to eight years of diagnosis delays significant cognitive decline, while early intervention optimizes physical mob...

SourceHackensack Meridian Health·JournalMovement Disorders·TypeObservational study·DateOct 6, 2026

Nine studies led by Mount Sinai investigators featured in coordinated collection of papers that map the molecular and cellular architecture of brain disorders

Researchers identified shared and disease-specific molecular changes in human brain tissue, contributing to neurodegeneration, psychiatric illness, and cognitive decline. The collection establishes a foundational resource for understanding brain disorders, accelerating discovery and therapy development.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature·TypeObservational study·DateSep 23, 2026

A new Stowers Institute brain atlas shows neurons don’t inherit their identity — they build it in their first hours of life

A new brain atlas reveals that neurons build their identity in the first hours of life, rather than inheriting it from their parent cells. The atlas, which mapped nearly 250,000 fly brain cells, shows that neuronal identity is established through a flexible, modular system involving different DNA switches and regulatory proteins.

SourceStowers Institute for Medical Research·JournalProceedings of the National Academy of Sciences·DateSep 10, 2026

Three herbal extracts protect mitochondrial function in a cellular model of Parkinson’s disease

Researchers found three herbal extracts protect mitochondrial function in a cellular model of Parkinson’s disease, suggesting a potential treatment. The extracts, including Uncaria rhynchophylla, Gardenia jasminoides, and Scutellaria baicalensis, improved cell viability and mitochondrial function in cells with reduced VPS13C expression.

SourceImpact Journals LLC·JournalAging-US·TypeNews article·DateSep 9, 2026

Little space and a lot of flow spark amyloid formation

Researchers from the University of Osaka found that a protein associated with amyloidogenic light chain disease forms amyloid in areas of constrained geometry when subjected to shear stress. This study, published in FEBS Journal, suggests that mechanical pressure and chemical inhibitors may help dissolve amyloids.

SourceThe University of Osaka·JournalFEBS Journal·TypeExperimental study·DateAug 26, 2026

Critical Path for Parkinson’s announces milestone publication highlighting FDA support for novel biomarker to advance precision medicine strategies

The publication of the alpha-synuclein seed amplification assay (αSyn-SAA) biomarker highlights a decade of collaborative progress in biomarker development. This milestone enables earlier testing of new treatments for Parkinson's disease, which could delay or prevent disease onset and progression.

Emergency diagnoses linked to poorer outcomes across wide range of conditions

A large population-based study found that emergency diagnoses are common across multiple conditions, including Parkinson’s disease and coronary heart disease, and are consistently associated with worse outcomes. The study suggests that emergency diagnosis is a common phenomenon across diverse diseases and is linked to higher mortality ...

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateAug 25, 2026

Tiny toxic protein clumps may hold the key to developing early diagnosis and new therapies for protein-misfolding diseases like Alzheimer’s

Researchers suggest that targeting tiny protein aggregates known as oligomers, which form early in the disease process, may lead to breakthroughs in treating protein-misfolding diseases. Oligomers are increasingly believed to drive cellular damage, and their early formation may be more toxic than large protein deposits.

SourceUniversity of Southern Denmark·JournalNature Reviews Chemistry·TypeSystematic review·DateAug 21, 2026

New uOttawa study suggests gene linked to Parkinson's disease holds clues to battling deadly bacterial infections

Researchers have discovered a gene linked to Parkinson's disease may also strengthen the body's ability to fight dangerous infections. The study found that a well-studied mutation in the LRRK2 gene increases the production of reactive oxygen species, making immune cells more effective at eliminating intracellular bacteria.

SourceUniversity of Ottawa·JournalCellular and Molecular Immunology·TypeImaging analysis·DateAug 19, 2026

New study helps explain why brain stimulation responses vary

Researchers analyzed EBRAINS-hosted brain data to determine that whole-brain activity patterns predict stimulation outcomes better than local recordings. Targeting specific sensorimotor and visual networks reduces response variability by up to 24%. This study highlights the value of open datasets for enabling large-scale analyses.

SourceEBRAINS·JournalBrain Stimulation·DateAug 14, 2026

Flexing new hope: Muscles may help protect the Parkinson's brain

Researchers found that exercise-induced molecular changes contribute to neuronal health, improving movement and quality of life in PD patients. Exercise types such as aerobic exercises, resistance training, balance training, and multimodal exercise were found to be helpful in reducing falls, disabilities, and improving brain function.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateAug 7, 2026

Study uses living human brain tissue to map how electric stimulation affects neurons, genetic activity

Researchers used real human brain tissue samples to test the underlying mechanisms of deep brain stimulation. They found that brain cells became more synchronized in communicating, similar to memory formation, while altering gene expression across different types of brain cells.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature·TypeExperimental study·DateAug 5, 2026

Bar-Ilan University study: Patients are being forced to become their own medical experts

A Bar-Ilan University study finds that patients with chronic illnesses often feel compelled to become experts in their condition due to inadequate healthcare systems. This phenomenon is referred to as 'forced agency,' where patients must acquire and evaluate medical knowledge without formal training, leading to an 'epistemic burden.'

SourceBar-Ilan University·JournalSocial Science & Medicine·DateJul 20, 2026

Drug candidate could help L-dopa work better for patients with Parkinson’s

Researchers have developed a new drug candidate, SB-0110, that boosts L-dopa's benefits while reducing dyskinetic side effects in animal models of Parkinson’s disease. The compound preserves the gene-activity patterns tied to L-dopa’s benefits while counteracting biological changes associated with dyskinesia.

SourceUniversity of California - San Diego·JournalScience Translational Medicine·TypeExperimental study·DateJul 15, 2026